TY - JOUR
T1 - Modular droplet injector for sample conservation providing new structural insight for the conformational heterogeneity in the disease-associated NQO1 enzyme
AU - Doppler, Diandra
AU - Sonker, Mukul
AU - Egatz-Gomez, Ana
AU - Grieco, Alice
AU - Zaare, Sahba
AU - Jernigan, Rebecca
AU - Meza-Aguilar, Jose Domingo
AU - Rabbani, Mohammad T.
AU - Manna, Abhik
AU - Alvarez, Roberto C.
AU - Karpos, Konstantinos
AU - Cruz Villarreal, Jorvani
AU - Nelson, Garrett
AU - Yang, Jay How
AU - Carrion, Jackson
AU - Morin, Katherine
AU - Ketawala, Gihan K.
AU - Pey, Angel L.
AU - Ruiz-Fresneda, Miguel Angel
AU - Pacheco-Garcia, Juan Luis
AU - Hermoso, Juan A.
AU - Nazari, Reza
AU - Sierra, Raymond
AU - Hunter, Mark S.
AU - Batyuk, Alexander
AU - Kupitz, Christopher J.
AU - Sublett, Robert E.
AU - Lisova, Stella
AU - Mariani, Valerio
AU - Boutet, Sébastien
AU - Fromme, Raimund
AU - Grant, Thomas D.
AU - Botha, Sabine
AU - Fromme, Petra
AU - Kirian, Richard A.
AU - Martin-Garcia, Jose Manuel
AU - Ros, Alexandra
N1 - Publisher Copyright:
© 2023 The Royal Society of Chemistry.
PY - 2023/5/30
Y1 - 2023/5/30
N2 - Droplet injection strategies are a promising tool to reduce the large amount of sample consumed in serial femtosecond crystallography (SFX) measurements at X-ray free electron lasers (XFELs) with continuous injection approaches. Here, we demonstrate a new modular microfluidic droplet injector (MDI) design that was successfully applied to deliver microcrystals of the human NAD(P)H:quinone oxidoreductase 1 (NQO1) and phycocyanin. We investigated droplet generation conditions through electrical stimulation for both protein samples and implemented hardware and software components for optimized crystal injection at the Macromolecular Femtosecond Crystallography (MFX) instrument at the Stanford Linac Coherent Light Source (LCLS). Under optimized droplet injection conditions, we demonstrate that up to 4-fold sample consumption savings can be achieved with the droplet injector. In addition, we collected a full data set with droplet injection for NQO1 protein crystals with a resolution up to 2.7 Å, leading to the first room-temperature structure of NQO1 at an XFEL. NQO1 is a flavoenzyme associated with cancer, Alzheimer's and Parkinson's disease, making it an attractive target for drug discovery. Our results reveal for the first time that residues Tyr128 and Phe232, which play key roles in the function of the protein, show an unexpected conformational heterogeneity at room temperature within the crystals. These results suggest that different substates exist in the conformational ensemble of NQO1 with functional and mechanistic implications for the enzyme's negative cooperativity through a conformational selection mechanism. Our study thus demonstrates that microfluidic droplet injection constitutes a robust sample-conserving injection method for SFX studies on protein crystals that are difficult to obtain in amounts necessary for continuous injection, including the large sample quantities required for time-resolved mix-and-inject studies.
AB - Droplet injection strategies are a promising tool to reduce the large amount of sample consumed in serial femtosecond crystallography (SFX) measurements at X-ray free electron lasers (XFELs) with continuous injection approaches. Here, we demonstrate a new modular microfluidic droplet injector (MDI) design that was successfully applied to deliver microcrystals of the human NAD(P)H:quinone oxidoreductase 1 (NQO1) and phycocyanin. We investigated droplet generation conditions through electrical stimulation for both protein samples and implemented hardware and software components for optimized crystal injection at the Macromolecular Femtosecond Crystallography (MFX) instrument at the Stanford Linac Coherent Light Source (LCLS). Under optimized droplet injection conditions, we demonstrate that up to 4-fold sample consumption savings can be achieved with the droplet injector. In addition, we collected a full data set with droplet injection for NQO1 protein crystals with a resolution up to 2.7 Å, leading to the first room-temperature structure of NQO1 at an XFEL. NQO1 is a flavoenzyme associated with cancer, Alzheimer's and Parkinson's disease, making it an attractive target for drug discovery. Our results reveal for the first time that residues Tyr128 and Phe232, which play key roles in the function of the protein, show an unexpected conformational heterogeneity at room temperature within the crystals. These results suggest that different substates exist in the conformational ensemble of NQO1 with functional and mechanistic implications for the enzyme's negative cooperativity through a conformational selection mechanism. Our study thus demonstrates that microfluidic droplet injection constitutes a robust sample-conserving injection method for SFX studies on protein crystals that are difficult to obtain in amounts necessary for continuous injection, including the large sample quantities required for time-resolved mix-and-inject studies.
UR - https://www.scopus.com/pages/publications/85163438295
U2 - 10.1039/d3lc00176h
DO - 10.1039/d3lc00176h
M3 - Article
C2 - 37294576
AN - SCOPUS:85163438295
SN - 1473-0197
VL - 23
SP - 3016
EP - 3033
JO - Lab on a Chip
JF - Lab on a Chip
IS - 13
ER -